業績   【相馬正義】

原著論文
135. Peng HUI, Tomohiro NAKAYAMA, Akihiko MORITA, Naoyuki SATO, Mikano HISHIKI, Kosuke SAITO, Yukie YOSHIKAWA, Masaaki TAMURA, Ichiro SATO, Teruyuki TAKAHASHI, Masayoshi SOMA, Yoichi IZUMI, Yukio OZAWA, and Zuheng CHENG. Common Single Nucleotide Polymorphisms in Japanese Patients with Essential Hypertension: Aldehyde Dehydorogenase 2 Gene as a Risk Factor Independent of Alcohol Consumption. Hypertens Res 2007; 30: 585-592

134. Sato M, Nakayama T, Soma M, Aoi N, Kosuge K, Haketa A, Izumi Y, Matsumoto K, Sato N, Kokubun S. Association between prostaglandin E2 receptor gene and essential hypertension. Prostaglandins Leukot Essent Fatty Acids. 2007 Jul;77(1):15-20. Epub 2007 Jul 20.

133. Kotoko Kosuge, Masayoshi Soma, Tomohiro Nakayama, Noriko Aoi, Mikano Sato, Yoichi Izumi, Koichi Matsumoto. A Nobel Variable Number of Tandem Repeat of the Natriuretic Peptide Precursor B gene’s 5’-Flanking Region is Associated with Essential Hypertension among Japanese Females. International Journal of Medical Sciences. 2007 4(3):146-152

132. Keisuke Yatsu, Nobuhisa Mizuki, Nobuhito Hirawa, Akira Oka, Norihito Itoh, Takahiro Yamane, Momoko Ogawa, Tadashi Shiwa, Yasuharu Tabara, Shigeaki Ohno, Masayoshi Soma, Akira Hata, Kazuwa Nakao, Hirotsugu Ueshima, Toshio Ogihara, Hitonobu Tomoike, Tetsuro Miki, Akinori Kimura, Shuhei Mano, Jerzy K. Kulski, Satoshi Umemura, Hidetoshi Inoko. High-Resolution Mapping for Essential Hypertension Using Microsatellite Markers. Hypertension. 2007; 49:446-452.

131. Morita A, Nakayama T, Soma M, Mizutani T. Association Between the Calcitonin-Related Peptide alpha (CALCA) Gene and Essential Hypertension in Japanese. Am J Hypertens, 2007 May; 20(5):527-32.

130. Takahiro Ueno, Yumiko Takahashi, Taro Matsumoto, Akiko Tsunemi, Hideyuki Watanabe, Kazunobu Tahira, Noboru Fukuda, Masayoshi Soma, Koichi Matsumoto. Postprandial plasma lipid levels are influenced by the interaction of functional polymorphisms in the microsome triglyceride transfer protein and β3 adrenergic receptor genes. Med Sci Monit, 2007; 13(5): BR112-118

129. 小牧宏一、相馬正義、坂田悍教、小菅琴子、青井則子、羽毛田公、中山智祥、岡本順子、細川武、土居通哉、五味敏明、松本紘一:高齢者住民検診における血漿高分子量アディポネクチン濃度。埼玉県立大学 紀要 8:33-37, 2006

128. Higuchi T, Yamazaki T, Ohnishi Y, Matsumoto S, Yabuki M, Kitajima S, Toshida Y, Maruyama N, Oikawa O, Okada K, Fukuda N, Soma M, Matsumot. A case report of hemodialysis intolerance with eosinophilia. Ther Apher Dial. 2007 Feb;11(1):70-3.

127. Morita A, Nakayama T, Doba N, Hinohara S, Mizutani T, Soma M. Genotyping of triallelic SNPs using TaqMan((R)) PCR. Mol Cell Probes. 2006 Nov 7

126. Yatsu K, Mizuki N, Hirawa N, Oka A, Itoh N, Yamane T, Ogawa M, Shiwa T, Tabara Y, Ohno S, Soma M, Hata A, Nakao K, Ueshima H, Ogihara T, Tomoike H, Miki T, Kimura A, Mano S, Kulski JK, Umemura S, Inoko H. High-resolution mapping for essential hypertension using microsatellite markers. Hypertension. 2007 Mar;49(3):446-52. Epub 2007 Jan 22.

125. Kaneko Y, Nakayama T, Saito K, Morita A, Sato I, Maruyama A, Soma M, Takahashi T, Sato N. Relationship between the thromboxane A2 receptor gene and susceptibility to cerebral infarction. Hypertens Res. 2006 Sep;29(9):665-71.

124. Saito K, Nakayama T, Sato N, Morita A, Takahashi T, Soma M, Usami R. Haplotypes of the plasminogen activator gene associated with ischemic stroke. Thromb Haemost 2006 Sep;96(3):331-6.

123. Omi T, Kumada M, Kamesaki T, Okuda H, Munkhtulga L, Yanagisawa Y, Utsumi N, Gotoh T, Hata A, Soma M, Umemura S, Ogihara T, Takahashi N, Tabara Y, Shimada K, Mano H, Kajii E, Miki T, Iwamoto S. An intronic variable number of tandem repeat polymorphisms of the cold-induced autoinflammatory syndrome 1 (CIAS1) gene modifies gene expression and is associated with essential hypertension. Eur J Hum Genet. 2006 Jul 26.

122. Nakayama T, Kuroi N, Sano M, Tabara Y, Katsuya T, Ogihara T, Makita Y, Hata A, Yamada M, Takahashi N, Hirawa N, Umemura S, Miki T, Soma M. Mutation of the follicle-stimulating hormone receptor gene 5'-untranslated region associated with female hypertension. Hypertension. 2006 Sep;48(3):512-8. Epub 2006 Jul 24.

121. Morita A, Nakayama T, Doba N, Hinohara S, Soma M. Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP Level and arterial pulse wave velocity in healthy elderly Japanese. Hypertens Res. 2006 May;29(5):323-31.

120. Morita A, Nakayama T, Soma M. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am J Hypertens 2006 Jun;19(6):593-600.

119. Higuchi T, Matsukawa Y, Okada K, Oikawa O, Yamazaki T, Ohnishi Y, Fujita T, Fukuda N, Soma M, Matsumoto K. Correction of Copper Deficiency Improves Erythropoietin Unresponsiveness in Hemodialysis Patients with Anemia. Intern Med 2006 May;45(5):271-3

118. Higuch T, Fukuda N, Yamamoto C, Yamazaki T, Oikawa O, Ohnishi Y, Soma M, Matsumoto K. The influence of uremic serum on interleukin-1β and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells. Therapeutic Apheresis and Dialysis 10(1):65-71, 2006

117. Sato N, Nakayama T, Asai S, Soma M. A haplotype in the human Sur2 gene is associated with essential hypertension. J Human Hypertension 2006, 20(1):87-90

116. Nakayama T, Asai S, Sato N, Soma M. Genotype and Haplotype Association Study of the STRK1 Region on 5q12 Among Japanese. A Case-Control Study. Stroke 2006 Jan;37(1):69-76

115. Kobayashi Y, Nakayama T, Sato N, Izumi Y, Kokubun S, Soma M. Haplotype-based case-control study revealing an association between the adrenomedullin gene and proteinuria in subjects with essential hypertension. Hypertens Res. 2005 Mar;28(3):229-36.

114. Kushiro T, Takahashi A, Saito F, Otsuka Y, Soma M, Kurihara T, Satomura A, Saito T, Kanmatsuse K. Erectile dysfunction and its influence on quality of life in patients with essential hypertension. Am J Hypertens. 2005 Mar;18(3):427-30.

113. Sano M, Kuroi N, Nakayama T, Sato N, Izumi Y, Soma M, Kokubun S. Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am J Hypertens. 2005 Mar;18(3):403-8.

112. Aoi N, Soma M, Nakayama T, Rahmutula D, Kosuge K, Izumi Y, Matsumoto K. Variable number of tandem repeat of the 5'-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. Hypertens Res. 2004 Oct;27(10):711-6.

111. 徳竹英一、相馬正義:HMG-CoA還元酵素阻害薬と長時間作用型Ca拮抗焼くとの併用による高脂血症を合併した高血圧患者の頚動脈内膜中膜肥厚度(IMT)の改善効果。Therapeutic Res 26(1):145-152, 2005.

110. Higuchi T, Yamamoto C, Kuno T, Okada K, Soma M, Fukuda N, Nagura Y, Takahashi S, Matsumoto K. A comparison of bicarbonate hemodialysis hemodiafiltration, and acetate-free biofiltration on cytokine production. Therapeutic Apheresis and Dialysis 8(6):460-467, 2004.

109. Nakayama T, Soma M, Sato N, Haketa A, Kosuge K, Aoi N, Sato M, Izumi Y, Matsumoto K, Kanmatsuse K, Kokubun S. An association study in essential hypertension using functional polymorphisms in lymphotoxin-alpha gene. Am J Hypertens. 2004 Nov;17(11 Pt 1):1045-9.

108. Haketa A, Soma M, Nakayama T, Sato M, Kosuge K, Aoi N, Matsumoto K. Two medium-chain acyl-coenzyme A synthetase genes, SAH and MACS1, are associated with plasma high-density lipoprotein cholesterol levels, but they are not associated with essential hypertension. J Hypertens. 2004 Oct;22(10):1903-7.

107. Nakayama T, Soma M, Kanmatsuse K, Kokubun S. The microsatellite alleles on chromosome 1 associated with essential hypertension and blood pressure levels. J Hum Hypertens. 2004 Jun 10 doi:10.1038/sj.jhh.1001740

106 Nakayama T, Soma M, Haketa A, Aoi N, Kosuge K, Sato M, Kanmatsuse K, Kokubun S. Haplotype analysis of the prostacyclin synthase gene and essential hypertension. Hypertens Res. 2003 Jul;26(7):553-7

105. Tomohiro Nakayama, Masayoshi Soma, Satoshi Saito, Junko Honye, Mikano Sato, Noriko Aoi, Kotoko Kosuge, Akira Haketa, Katsuo Kanmatsuse, Shinichiro Kokubun. Missense mutation of exon 3 in the type A human natriuretic peptide receptor gene is associated with myocardial infarction. Med Sci Monit, 2003, 9(12):CR505-510

104. Takahiro Ueno, Emi Shimazaki, Taro Matsumoto, Hideyuki Watanabe, Akiko Tsunemi, Yumiko Takahashi, Mayumi Mori, Rumi Hamano, Toshiyuki Fujioka, Masayoshi Soma, Koichi Matsumoto, Katsuo Kanmatsuse. Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population. Med Sci Monit, 2003; 9(6): CR260-264

103. Hasimu B, Nakayama T, Mizutani Y, Izumi Y, Asai S, Soma M, Kokubun S, Ozawa Y. A novel variable number of tandem repeat polymorphism of the renin gene and essential hypertension. Hypertens Res. 2003 Jun;26(6):473-7.

102. Nakayama T, Soma M, Watanabe Y, Hasimu B, Kanmatsuse K, Kokubun S, Morrow JD, Oates JA. Splicing mutation of the prostacyclin synthase gene in a family associated with hypertension. Adv Exp Med Biol 2003;525:165-8

101. Hasimu B, Nakayama T, Mizutani Y, Izumi Y, Asai S, Soma M, Kokubun S, Ozawa Y. Haplotype analysis of the human renin gene and essential hypertension. Hypertension 2003 Feb;41(2):308-12

100. Fukuda N, Nakayama M, Jian T, Satoh C, Nakayama T, Soma M, Izumi Y, Kanmatsuse K. Leukocyte angiotensin II levels inpatients with essential hypertension:relation to insulin resistance. Am J Hypertens 2003 Feb;16(2):129-34.

99. 相馬正義、中山智祥、松本紘一、上松瀬勝男。塩酸バルニジピン長期投与の血圧日内変動、レニン・アンジオテンシン・アルドステロン系、腎機能、糖代謝および脂質代謝に対する効果について。医学と薬学 49(1):93-101, 2003.1

98. Nakayama T, Soma M, Watanabe Y, Hasimu B, Sato M, Aoi N, Kosuge K, Kanmatsuse K, Kokubun S, Marrow J, Oates J. Splicing mutation of the prostacyclin synthase gene in a family associated with hypertension. Biochem Biophys Res Commun 2002 Oct 11;297(5):1135-1139

97. Okada K, Onishi Y, Nagura Y, Soma M, Saito S, Kanmatsuse K, Takahashi S. Sclerosing encapsulating peritonitis: Regional changes of peritoneum. Nephron 2002 Oct;92(2):481-3

96. Nakayama T, Soma M, Mizutani Y, Xinjuan Xu, Honye J, Kaneko Y, Rahmutula D, Aoi N, Kosuge K, Saito S, Kanmatsuse K, Kokubun S. A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: Possible association with essential hypertension. Hypertens Res. 2002 May;25(3):395-401.

95. Nakayama T, Soma M, Saito S, Honye J, Yajima J, Rahmutula D, Kaneko Y, Sato M, Uwabo J, Aoi N, Kosuge K, Kunimoto M, Kanmatsuse K, Kokubun S. Association of a novel single nucleotide polymorphism of the prostacyclin synthase gene with myocardial infarction. Am Heart J 2002 May;143(5):797-801

94. Rahmutula D, Nakayama T, Soma M, Kosuge K, Aoi N, Izumi Yoichi, Kanmatsuse K and Ozawa Y: Structure and Polymorphisms of the Human Natriuretic Peptide Receptor C Gene. Endocrine 2002 17(2):85-90.

93. Nakayama T, Soma M, Rahmutula D, Tobe H, Sato M, Uwabo J, Aoi N, Kosuge K, Kunimoto M, Kanmatsuse K, Kokubun S: Association study between a novel single nucleotide polymorphism of the promoter region of the prostacyclin synthase gene and essential hypertension. Hypertens Res. 2002 Jan;25(1):65-8.

92. Soma M, Nakayama T, Rahmutula D, Uwabo J, Sato Mikano, Kunimoto M, Aoi N, Kosuge K and Kanmatsuse K. Ser9Gly Polymorphism in the Dopamine D3 Receptor Gene is not Associated with Essential Hypertension in the Japanese. Med Sci Monit. 8;CR1-4, 2002.1

91. Nakayama T, Minato M, Nakagawa M, Soma M, Tobe H, Aoi N, Kosuge K, Sato M, Ozawa Y, Kanmatsuse K, Kokubun S: A novel mutation in the Ca2+-Sensing Receptor Gene in Familial Hypocalciuric Hypercalcemia. Endocrine 15: 277-282, 2001.

90. Nakayama T, Soma M, Rahmutula D, Kanmatsuse K: Mutation of the human prostacyclin synthase gene. Advances in Prostaglandin and Leukotriene Research 65-68, 2001.

89. Rahmutula D, Nakayama T, Soma M, Sato M, Izumi Y, Kanmatsuse K, Ozawa Y. Systematic screening of type B human natriuretic peptide receptor gene polymorphisms and association with essential hypertension. J Hum Hypertens 15(7):471-4, 2001.7

88. Nakayama T, Soma M, Rahmutula D, Ozawa Y, Kanmatsuse K. Isolation of the 5'-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction. Med Sci Monit. 7(3):345-9, 2001.5

87. Nakayama T, Soma M, Takahashi Y, Rehemudula D, Tobe H, Sato M, Uwabo J, Kunimoto M, Izumi Y, Kanmatsuse K. Polymorphism of the promoter region of prostacyclin synthase gene is not related to essential hypertension. Am J Hypertens. 14(5 Pt 1):409-11, 2001.5

86. Nakayama T, Soma M, Rehemudula D, Takahashi Y, Tobe H, Satoh M, Uwabo J, Kunimoto M, Kanmatsuse K. Association of 5' upstream promoter region of prostacyclin synthase gene variant with cerebral infarction. Am J Hypertens 13(12):1263-7, 2000.12

85. Rahmutula D, Nakayama T, Soma M, Takahashi Y, Uwabo J, Sato M, Izumi Y, Saito S, Honye J, Kanmatsuse K, Ozawa Y. A C2077T polymorphism of the type B human natriuretic peptide receptor gene is not associated with myocardial infarction. Med Sci Monit 6(6): 1053-1055, 2000.12

84. Sato M. Soma M, Nakayama T, Kanmatsuse K. Dopamine D1 Receptor Gene Polymorphism is Associated with Essential Hypertension. Hypertension 36(2):183-186, 2000.8

83. 泉 洋一、福田 昇、中山智祥、渡辺吉康、相馬正義、上松瀬勝男。降圧薬1日飲み忘れによる血圧の変化。新薬と臨床 49(6):601-606, 2000.6

82. Nakayama T, Soma M, Takahashi Y, Rehemudula D, Kanmatsuse K, Furuya K. Functional deletion mutation of the 5'-flanking region of the type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res. 2000 Apr 28;86(8):841-845.

81. Kawamura H, Jumabay M, Mitsubayasi H, Izumi Y, Soma M, Ozawa Y, Rehemudula D, Mahmut M, Hu Y, Aisa M, Cheng ZH, Wang Zhen. 24-hour blood pressure in Uygur, Kazakh and Han elderly subjects in China. Hypertens Res 23(2): 177-185, 2000.3

80. Rahmutula D, Nakayama T, Soma M, Takahashi Y, Uwabo J, Sato M, Izumi Y, Kanmatsuse K, Ozawa Y. An Insertion/Deletion Polymorphism in Intron 18 of the Type B Human Natriuretic Peptide Receptor Gene Is Not Associated with Cerebral Infarction. Hypertens Res 23(2): 173-176, 2000.3

79. Fukuda N, Hu WY, Kubo A, Kishioka H, Satoh C, Soma M, Izumi Y, Kanmatsuse K. Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells. Am J Hypertens 13(2):191-8, 2000.2

78. Nakayama T, Soma M, Takahashi Y, Rehemudula D, Sato M, Uwabo J, Izumi Y, Kanmatsuse K. Nucleotide sequence of the 5'-flanking region of the type A human natriuretic peptide receptor gene and association analysis using a novel microsatellite in essential hypertension. Am J Hypertens 12:1144-1148, 1999.11

77. Nakayama M, Fukuda N, Watanabe Y, Soma M, Hu WY, Kishioka H, Satoh C, Kubo A, Kanmatsuse K. Low dose of eicosapentaenoic acid inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats through suppression of transforming growth factor-beta. J Hypertens 17:1421-30, 1999.10

76. Fukuda N, Satoh T, Hu W-Y, Soma M, Kubo A, Kishioka H, Watanabe Y, Izumi Y, Kanmatsuse K. Production of angiotensin II by homogenous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vascu Biol 19:1210-1217, 1999.3

75. Duolikun R, Nakayama T, Soma M, Takahashi Y, Uwabo J, Sato M, Yoichi I, Kanmatsuse K, Ozawa Y. Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension. Cir Res 84:605-610, 1999.

74. Hu W.-Y, Fukuda N, Soma M, Izumi Y, Kanmatsuse K. Bunazosine hydrochloride inhibits exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats by suppressing the response to growth factors. J Cardiovasc Pharmacol 32:975-982, 1998.12

73. 相馬正義、福田昇、泉洋一、渡辺吉康、上松瀬勝男:塩酸ブナゾシン徐放性製剤の降圧効果と心・腎・内分泌代謝系に及ぼす影響。医学と薬学、40:1047-1056, 1998.12

72. Soma M, Nakayama T, Satoh M, Uwabo J, Duolikun R, Takahashi Y, Fukuda N, Watanabe Y, Izumi Y and Kanmatsuse K. A T1083C polymorphism in the human adenosine A2a receptor gene is not associated with essential hypertension. Am J Hypertens 11:1492-1494, 1998.12

71. Kunimoto M. Soma M and Kanmatsuse K. Production of eicosanoid and angiotensin II in resistance vessels in spontaneously hypertensive rats. Clin Experi Pharmacol Physiol 25:430-434, 1998.7

70. Takahashi Y, Nakayama T, Soma M, Izumi Y, Kanmatsuse. Organization of the human natriuretic peptide receptor A gene. Biochem Biophys Res Commun. 246: 736-739, 1998.5

69. Fukuda N, Hu W.-Y, Kubo A, Endoh M, Kishioka H, Satoh T, Soma M, Izumi Y, Kanmatsuse K. Abnormal regulation of transforming growth factor-βreceptor on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II. Hypertension 31:672-677, 1998.4

68. 中山智祥、相馬正義、上松瀬勝男:ヒトプロスタサイクリン合成酵素遺伝子の5'上流領域の増幅と新しい多型の発見。日大医学雑誌 57:24-28, 1998.1

67. 羽毛田 公、相馬正義、中山智祥、泉 洋一、上松瀬勝男:アンジオテンシノーゲン遺伝子多型M235Tと本態性高血圧症および左室肥大との関連性の検討。日大医学雑誌 57:12-16, 1998.1

66. Uwabo J, Soma M, Nakayama T, Kanmatsuse K: Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens 11:125-128, 1998.1

65. T. Nakayama, Izumi Y, Soma M, Kanmatsuse K. Adrenal renin-angiotensin-aldosterone system in streptozotocin-diabetic rats. Horm Metab Res 30:12-15, 1998.

64. Hu WY, Nakayama T, Fukuda N, Kishioka H, Soma M, Izumi Y, Kanmatsuse K. Sequences of exon 6 and the adjacent intron boundaries of the rat platelet-derived growth factor A-chain gene: Implications for alternative splicing. Biochemical Genetics 35:395-405, 1997.

63. Fukuda N, Kishioka H, Satoh C, Nakayama T, Watanabe Y, Soma M, Izumi Y, Kanmatsuse K. Role of long-form PDGF A-chain in the growth of vascular smooth muscle cells from spontaneously hypertensive rats. Am J Hypertens 10:1117-1124, 1997.10

62. Fukuda N, Kubo A, Watanabe Y, Nakayama T, Soma M, Izumi Y, Kanmatsuse K. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures. J Hypertens 15:1123-1136,1997.10

61. Nakayama T, Soma M, Rahmudula D, Izumi Y, Kanmatsuse K. Nonsense mutation of prostacyclin synthase gene in a family. Lancet 349:1887-1888, 1997.6

60. Fukuda N, Soma M, Kubo A, Kunimoto M, Watanabe Y, Izumi Y and Kanmatsuse K. Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism. J Endocrinol Invest 20:13-17, 1997.

59. Takahashi Y, Nakayama T, Soma M, Uwabo J, Izumi Y, Kanmatsuse K. Association analysis of TG repeat polymorphism of the neuronal nitric oxide synthase gene with essential hypertension. Clinical Genetics 52:83-85, 1997.

58. Nakayama T, Soma M, Takahashi Y, Uwabo J, Izumi Y, Kanmatsuse K. Novel polymorphic CA/TG repeat identified in the human prostacyclin synthase gene. Human Heredity 47: 176-177, 1997.

57. 相馬正義、福田昇、泉洋一、渡辺吉康、上松瀬勝男:塩酸ベタキソロールの日内変動、レニンーアンジオテンシンーアルドステロン系、腎機能、糖代謝および脂質代謝に対する効果について。薬理と治療 25: 1185-1193, 1997.

56. Nakayama T, Soma M, Takahashi Y, Izumi Y, Kanmatsuse K and Esumi M: Association analysis of CA repeat polymorphism of endothelial nitric oxide sythase gene with essential hypertension in Japanese. Clinical Genetics 51:26-30, 1997.

55. 相馬正義、福田昇、渡辺吉康、泉洋一、上松瀬勝男:血圧日内変動、腎機能、糖代謝、脂質代謝およびレニン-アンジオテンシン-アルドステロン系に対する塩酸イミダプリルの効果について。医学と薬学 37:187-195, 1997.

54. Takahashi Y, Nakayama T, Soma M, Izumi Y and Kanmatsuse K: CA repeats polymorphism of the neuronal nitric oxide synthase gene. Human Heredity 47:58-59, 1997.

53. 相馬正義、泉洋一、福田昇、渡辺吉康、上松瀬勝男:血圧日内変動からみた塩酸テモカプリル(エースコール)の降圧効果について。Geriat Med 34:1695-1698, 1996.12.

52. Izumi Y, Matsuoka M, Kubo A, Nakayama T, Fukuda N, Watanabe Y, Soma M and Kanmatsuse K: Prevention of cardiac hypertrophy by a sub-antihypertensive dose of the α1-adrenergic antagonist Bunazosin in Dahl salt-sensitive rats. Hypertension Research 19, 147-150, 1996.

51. Nakayama T, Soma M, Izumi Y, and Kanmatsuse K: Organization of the human prostacyclin synthase gene. Biochemical and Biophysical Research Communications 221, 803-806, 1996.

50. Kubo A, Fukuda N, Soma M, Izumi Y, and Kanmatsuse K: Inhibitory effect of an angiotensin II type 1 receptor antagonist of growth of vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovascular Pharmacol 27:58-63, 1996.

49. Nakayama T, Izumi Y, Soma M and Kanmatsuse K: Nitric oxide synthesis inhibitor prevents the ACTH-stimulated production of aldosterone in rat adrenal gland. Endocrine Journal 43:157-162, 1996.4

48. Soma M, Izumi Y, Watanabe Y, Kanmatsuse K: A nitric oxide synthesis inhibitor decreased prostaglandin production in rat mesenteric vasculature. Prostaglandins 51:225-232, 1996.

47. 國本昌子、相馬正義、泉洋一、上松瀬勝男:ラット腸管膜抵抗血管に対するnipradilolの血管拡張作用の検討。Therapeutic Research 16:2689-2696, 1995.8

46. Fukuda N, Kubo A, Izumi Y, Soma M, Kanmatsuse K: Distinct expression of taransforming growth factor-b receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats and Wistar-Kyoto rats. Clin Experi Pharmacol Physiol. supple1, S120-122, 1995.

45. Fukuda N, Kubo A, Izumi Y, Soma M and Kanmatsuse K: Characteristics and expression of transforming growth factor-β receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 13:831-837, 1995.10

44. 中山智祥、田沼美昭、相馬正義、上松瀬勝男、大和田操、中林啓記、江角真理子:インスリン非依存性糖尿病と筋型グリコーゲン合成酵素遺伝子マイクロサテライト多型との関連。日本内分泌学会誌、71:597-604, 1995.

43. Nakayama T, Soma M, Izumi Y, Kanmatsuse K, Esumi M: CA repeat polymorphism of the endotheial nitric oxide synthase gene in Japanese. Human Heredity 45:301-302,1995.8

42. Ito M. Soma M, Kammatsuse K: Effects of long-term treatment with angiotensin converting enzyme inhibitor on angiotensin II and prostacyclin release from mesenteric arteries in spontaneously hypertensive rats. Prostaglandin Leukotrien and EFAs, 53:359-363, 1995.11

41. Ito M, Fukuda N, Izumi Y, Watanabe Y, Watanabe M. Soma M, Kammatsuse K: Enhancement effect of carteorol on the clonidine-induced vasodilation of rat mesenteric arteries. Pharmacological Research 31:319-323, 1995.5

40. 天野定雄、黒須康彦、秦怜志、柴田昌彦、三宅洋、滝沢秀博、宗像敬明、相馬正義、上松瀬勝男:のう胞性甲状腺腫に対するエタノール注入療法。日大医学雑誌 53:pp529-532, 1994.6

39. Nakayama T, Imai S, Soma M, Izumi Y, Kanmatsuse K: Compensatory adrenal growth and steroidgenesis after unilateral adrenectomy. Endocrine Journal 40:pp523-527, 1993.10

38. 蔵本築、相馬正義、他28名:塩酸デラプリルのQOLに対する影響の検討。Geriatric Medicine 31:559-568, 1993.4

37. 中山智祥、相馬正義、影浦博信、阿部好伸、伊藤みき、渡辺昌司、渡辺吉康、泉洋一、波多野道信:Sipple症候群における高血圧型と尿中カテコラミンについて。日本内分泌学会雑誌 68:pp.39-50, 1992.1

36. Fukuda N, Y. Izumi, M. Soma, Y. Watanabe, M. Watanabe, and M. Hatano: Effects of L-NG-Monometyl arginine on the cyclic GMP formation in rat mesenteric arteries. Japanese Journal of Pharmacology 58:55-60, 1992.

35. Watanabe M, Y. Izumi, M. Soma, Y. Watanabe, N. Fukuda, Y. Abe, M. Ito, H. Kageura, T. Nakayama, M. Hatano: Effect of endothelin-3 (ET-3) on renal function in rat perfused kidney. Endocrinologica Japonica 38:435-440, 1991.8

34. Fukuda N, Y. Izumi, M. Minato, M. Soma, Y. Watanabe, M. Watanabe, and M. Hatano: Cyclic GMP formation of resistance vessels in the development of hypertension in spontaneously hypertensive rats. Japanese Circulation Journal 55:721-726, 1991.7

33. Fukuda N, M. Soma, Y. Izumi, M. Minato, Y. Watanabe, M. Watanabe, M. Hatano: Low doses of endothelin-3 elicit endothelium dependent vasodilation which accompanies with elevation of cyclic GMP. Japanese Circulation Journal 55:pp.617-622, 1991.6

32. Fukuda N, Y. Izumi, M. Soma, Y. Watanabe, M. Watanabe, M. Hatano, I. Sakuma, H. Yasuda: Effects of Indomethacin, Endothelium-Denudation, Methylene Blue and L-NG-Monometyl arginine on the Vasoactive Effects of Endothelin-3. Japanese Journal of Pharmacol 55:375-380, 1991.9

31. Watanabe M, M. Honda, M. Soma, M. Minato, N. Fukuda, Y. Watanabe, Y. Izumi, M. Hatano: Preventive effect of angiotensin I on weight reduction in the adrenal glands of DOCA/Salt hypertensive rats. Endocrinologica Japonica 37:pp.521-528, 1990.

30. Izumi Y, M. Honda, N. Fukuda, M. Watanabe, Y. Watanabe, M. Soma, M. Hatano: Effect of arterial natriuretic peptide on adrenal renin and aldosterone. Endocrinologica Japonica 37:pp.47-52, 1990.

29. Fukuda N, M. Honda, M. Minato, M. Soma, Y. Izumi, and M. Hatano: Adenylate cyclase activities of vascular smooth muscle in early and established DOCA/Salt hypertensive rat. Japanese Circulation Journal 54:pp.82-88, 1990.

28. Fukuda N, Y. Izumi, M. Soma, Y. Watanabe, M. Watanabe, M. Hatano, I. Sakuma, H. Yasuda: L-NG-Monometyl arginine inhibits the vasodilating effects of low dose of endothelin-3 on rat mesenteric arteries. Biochemical and Biophysical Research Communications 167:739-745, 1990.

27. Watanabe M, M. Honda, M. Minato, N. Fukuda, M. Soma, Y. Watanabe, Y. Izumi, M. Hatano: Measurement of intracellular free calcium in human platelets. Nihon University Journal of Medicine 32:123-129, 1990.

26. 渡辺吉康、泉洋一、相馬正義、福田昇、渡辺昌司、波多野道信:非観血的携帯型自動血圧計による降圧薬の評価-塩酸アロチノロ-ルの血圧日内変動に及ぼす効果-。新薬と臨床 40:pp151-154, 1990.1

25. 相馬正義、泉洋一、渡辺吉康、福田昇、渡辺昌司、波多野道信:非観血的携帯型自動血圧計による降圧剤の評価-持効性Nifedipineについて-。診療と新薬 27:1729-1732, 1990.

24. 渡部昌司、渡部昌司、相馬正義、湊昌也、福田昇、渡辺吉康、永嶋康夫、泉洋一、波多野道信:非観血的携帯型自動血圧計による降圧効果の評価-カプトプリル25mg1日2回投与について- Progress in Medicine 9:pp.1656-1658, 1989.5

23. 湊昌也、本多正信、相馬正義、波多野道信:C19ステロイドの昇圧機序について-外因性昇圧物質に対する昇圧反応。日大医学雑誌48:pp581-585, 1989

22. 本多正信、湊昌也、高山亮子、渡部昌司、福田昇、相馬正義、永嶋康夫、泉洋一、渡辺吉康、白土寿、波多野道信、栗本文彦、桜井兵一郎、有賀とし弥:19-hydrozyandrostenedioneの昇圧機序についての研究。日本内分泌学会雑誌 65:18-31, 1989

21. 相馬正義、泉洋一、渡辺吉康、福田昇、波多野道信:血管壁 Eicosanoids 産生に及ぼすMg欠乏の影響について。マグネシウム 8:pp.25-28, 1989.1

20. 相馬正義、本多正信、永嶋康夫、渡部昌司、湊昌也、福田昇、波多野道信:非観血的携帯型自動血圧計による降圧剤の評価-Indapamideについて-。基礎と臨床 22:291-294, 1988.12

19. 本多正信、湊昌也、渡部昌司、福田昇、相馬正義、永嶋康夫、渡辺吉康、泉洋一、白土寿、波多野道信:高血圧自然発症ラット (SHR) における新しいCa拮抗薬 Franidipine (CV-4093 2HCl) の血圧および内分泌系因子に与える効果について。日本脈管学会雑誌 28:1075-1081, 1988.12

18. Soma M, SC. Cunnane, DF. Horrobin, MS. Manku, M. Honda, and M. Hatano: Effects of low magnesium diet on the vascular prostaglandin and fatty acid metabolism in rats. Prostaglandins 36:pp431-441, 1988.4

17. 小倉敏嗣、佐藤光重、相馬正義、斎藤友昭:心不全症例に対するurinastatinの使用経験。臨床と研究64:319-323,1987.9

16. Fujii K, Soma M, Huang YS, Manku MS and Horrobin DF: Increased release of prostaglandins from the mesenteric vascular bed of diabetic animals: the effects of glucose and insulin. Prostaglandins Leukot Med 24:151-161, 1986.10

15. 相馬正義、本多正信、湊昌也、波多野道信:Nicardipine Hydrochloride (Perdipine) の肝血流に及ぼす影響について。基礎と臨床20:pp4907-4909,1986.9

14. Fujii K, Soma M, Huang YS, Manku MS and Horrobin DF: Effect of glucose and insulin on release of prostaglandins from the mesenteric vascular bed in control and storeptozotocin diabetic animal. Progress in Lipid Research 25:503-505, 1986

13. Fujii K, Soma M, Huang YS, Manku MS and Horrobin DF: Increased release of prostaglandins from the mesenteric vascular bed in streptozotocin diabetes. Progress in Lipid Research 25:499-501, 1986.7

12. Manku M.S, Soma M and Horrobin DF. Effects of feeding gamma-linolenic acid on mesenteric and urinary prostaglandin outflow in guinea-pig. Progress in Lipid Research 25:309-310, 1986.7

11. Soma M. Fatty acid metabolism and PGI2 synthesis in mesenteric arterial beds in spontaneously hypertensive rats. Progress in Lipid Research 25:323-326, 1986.7

10. Soma M. Effects of cholesterol feeding on platelet thromboxane synthesis and vascular prostaglandins in rats. Progress in Lipid Research 25:205-206, 1986.7

9. 本多正信、高山亮子、福田昇、湊昌也、渡辺昌司、永嶋康夫、相馬正義、白土寿、泉洋一、波多野道信:Ca拮抗薬によるヒト血中および尿中ProstaglandinsとThromboxane B2の動態について。日本腎臓学会雑誌28:799-806, 1986.6

8. Cunnane S.C., Soma M, McAdoo KR and Horrobin DF. Magnesium deficiency in the rat increased tissue levels of docosahexaenoic acid. Journal of Nutrition 115:1498-1503, 1985.12

7. Soma M, Manku MS, Jenkins DK, Huang Y-S and Horrobin DF. Effects of dietary saturated, n-6 and n-3 polyunsaturated fats on blood pressure and prostaglandins outflow from perfused mesenteric vascular bed in rats. Prostaglandins 30:969-980, 1985.12

6. Soma M, Manku MS and Horrobin DF. The effects of hydrogenated coconut oil, safflower oil, and evening primrose oil on development of hypertension and sodium handing in spontaneously hypertensive rats. Canadian Journal of Physiology and Pharmacology 63:325-330, 1985.10

5. Soma M, Manku MS, Jenkins DK and Horrobin DF. Prostaglandins and thromboxane outflow from the perfused mesenteric vascular bed in spomtaneously hypertensive rats. Prostaglandins 29:323-333, 1985.7

4. 高山亮子、本多正信、渡辺吉康、福田昇、永嶋康夫、井上毅、湊昌也、渡辺昌司、白土寿、泉洋一、相馬正義、波多野道信:腎機能障害を合併した高血圧患者の腎機能に及ぼすConverting enzyme inhibitor (CEI) 長期投与の影響。新薬と臨床34:pp.425-431,1985.3

3. Honda M, Tsuchiya M, Manabe R, Watanabe Y, Inoue T, Nagashima Y, Izumi Y, Soma M, Watanabe H, Shiratsuchi T, Ueda Y, Fukuda N, Minato M, Watanabe M, Hatano M: Effects of prostacyclin on the responses of blood pressure and several hormones in normotensive subjects. Japanese Journal of Nephrology 26:1235-1241, 1984.9

2. Soma M, Honda M, Hatano M: Effects of angiotensin II and angiotensin III on prostacyclin release in man. Japanese Journal of Nephrology 25:1093-1101, 1983.9

1. Honda M, Watanabe H, Inoue T, Soma M, Manabe R, Izumi Y: Study on the hypotensive mechanism of angiotensin I converting enzyme inhibitor (SQ 14,225) in the acute phase. The Nihon University Journal of Medicine 24:1982.3


 このページのトップへ戻る

症例報告
24. 降籏隆二、平野亘、河合真紀子、久保英之、内山真、小菅琴子、田平佳子、伊田則子、相馬正義、松本紘一:悪性症候群を呈したACTH単独欠損症を伴った統合失調症の一例。日大医学雑誌 66(1):110-115,2007.2

23. Higuchi T, Yamazaki T, Ohnishi Y, Matsumoto S, Yabuki M, Kitajima S, Toshida M, Maruyama Y, Oikawa O, Okada K, Fukuda N, Soma M, Matsumoto K.A case report of hemodialysis intolerance with eosinophilia. Ther Apher Dial. 2007 Feb;11(1):70-3.

22. Sato M, Soma M, Nakayama T, Kosuge K, Suzuki R, Okada K, Komatsu K, Sugitani M, Matsumoto K. A case of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) with primary hyperparathyroidism. Endocrine Journal 2006, 53(1):111-117.

21. 山崎俊男、樋口輝美、大西貞彦、松本史郎、矢吹美奈子、北島尚子、及川冶、丸山範晃、羽木千尋、岡田一義、福田昇、藤田宣是、相馬正義、松本紘一:Hypereosinophiliaを呈した透析困難症の一例。日大医学雑誌 64(3):160-163,2005

20. 松崎真和、相馬正義、佐藤三佳乃、鈴木亮、赤羽正史、岡田一義、松本紘一、上松瀬勝男、岡田清巳、石田肇、平野大作、杉谷雅彦:ACTH非依存性両側副腎皮質大結節性過形成(AIMAH)の一例。日大医学雑誌 62(2):121-125, 2003

19. 中山智祥、山口賢二、及川 治、相馬正義、泉 洋一、小沢友紀雄、上松瀬勝男、柚木隆寛、平野大作、高橋雪絵、斎藤友昭:副腎腺腫によるクッシング症候群の一例。板橋区医師会医学会誌 5:pp.201〜203, 2001.5

18. 天野定雄、久保井洋一、斉藤良人、西尾知、大原守貴、根津健、三宅洋、大井田尚継、秦怜志、福沢正洋、相馬正義、上松瀬勝男:内視鏡補助下甲状腺部分切除および副甲状腺摘出術の経験。日大医学雑誌 60:144-148, 2001.3

17. Nakayama T, Nakayama K, Takahashi Y, Ohkubo K, Tobe H, Soma M, Ozawa Y, Kanmatsuse K, Nakamura M, Hironaga T, Makizumi Y, Nagura H: Case of spinocerebellar ataxia type 1 showing high intensity lesions in the frontal white matter on T2-weighted magnetic resonance images. Med Sci Monit 7(2):299-303, 2001. 4

16. Nakayama T, Asai Y, Soma M, Aoki K, Tobe H, Ozawa Y, Kanmatsuse K, Nezu T, Amano S. A family with multiple endocrine neoplasia type 2A. Nihon Univ J Med 41'309-318, 1999.10

15. 高橋雪絵、福田昇、相馬正義、泉洋一、上松瀬勝男:内分泌異常を伴いオクトレオチドが奏功した線維性骨異形成の1例。ホルモンと臨床 ’96夏期増刊号 内分泌興味ある症例 第28集 pp101-103, 1996.8

14. 中山麻里、福田昇、渡辺吉康、相馬正義、泉洋一、上松瀬勝男:オクトレオチドが奏功したネルソン症候群の1例。ホルモンと臨床 ’96夏期増刊号 内分泌興味ある症例第28集 pp101-103, 1996.8

13. 細川留美、相馬正義、鳴瀬裕爾、渡辺昌司、森内正人、大井洋之、上松瀬勝男:Empty sellaを伴うACTH単独欠損症の一例。日大医学雑誌 55:95-100, 1996.2

12. 宋滋章、磯村政保、渡辺太次郎、飯島隆紀、田中直英、相沢敏晴、伊藤和郎、岩崎有良、松尾裕、相馬正義、泉洋一、岡野国雄:ACTH単独欠損症の一例。日大医学雑誌 52:pp35-42, 1993.1

11. 中山智祥、相馬正義、久保淳、松岡昌子、阿部好伸、伊藤みき、渡辺昌司、渡辺吉康、泉洋一、八杉忠夫:妊娠合併のCushing症候群-自験例副腎腺腫1例と文献的考察-。日本内分泌学会誌 68:pp.1130-1149, 1992.10

10. 阿部好伸、相馬正義、松岡昌子、中山智祥、伊藤みき、渡辺昌司、渡辺吉康、泉洋一、八杉忠夫: Cushing症候群を呈した副腎腺腫として手術され約10年後に再発した副腎癌の一例。ホルモンと臨床 40巻秋季増刊号 内分泌興味ある症例 20集:pp.141-144, 1992.10

9. 伊藤みき、泉洋一、相馬正義、八杉忠夫:プロラクチン産生腫瘍にGraves病、IgA腎症をともなった症例。ホルモンと臨床 40巻秋季増刊号 内分泌興味ある症例 第19集:pp.93-98, 1992.4

8. 奈尾俊子、相馬正義、渡辺昌司、渡辺吉康、泉洋一、波多野道信:慢性甲状腺炎を合併したACTH単独欠損症の一例。ACTH RELATED PEPTIDS 2:pp.96-101, 1991.2

7. 笠巻祐二、松本太郎、小松一俊、相馬正義、栃原敏彦、奈倉勇爾、小沢友紀雄、波多野道信、沼口満津男:高齢で腹部大動脈瘤破裂をきたした1例。日本臨床内科医会会誌 4:63-65, 1990.

6. 相馬正義、本多正信、湊昌也、渡辺昌司、福田昇、永嶋康夫、泉洋一、白土寿、波多野道信:バ-タ-症候群様病態を呈した3症例。ホルモンと臨床 11:pp.217-220, 1989. '89春季増刊号

5. 湊昌也、本多正信、渡辺昌司、福田昇、相馬正義、永嶋康夫、泉洋一、白土寿、波多野道信:内分泌学的異常、Adams-Stokes様発作、心膜液貯留、脳萎縮を伴った神経性食欲不振症の一男性例。日本内科学会雑誌 77:pp.1417-1420, 1988.9

4. 渡辺吉康、本多正信、水野学、井上毅、岸均、泉洋一、真鍋亮子、渡部秀人、永嶋康夫、相馬正義、白土寿、波多野道信、佐々英一:著名な塩類喪失を示した下垂体機能低下症の一例。ホルモンと臨床 '83増刊号:pp30-35, 1983

3. 相馬正義、本多正信、波多野道信: Cushing症候群を呈した副腎皮質癌の1症例。ホルモンと臨床 '82増刊号:pp201-205, 1982.

2. 植田康久、本多正信、藤岡孝之、相馬正義、永嶋康夫、井上毅、土屋真、泉洋一、白土寿、波多野道信:特発性アルドステロン症の1例。日大医学雑誌 41:pp321-327, 1982.3

1. 相馬正義、本多正信、波多野道信:Cushing Syndromeを呈した副腎癌の1例について。第1回op'-DDD研究会議事録:pp.60-66, 1980.2


 このページのトップへ戻る

総説
10. 相馬正義:PBLテュトーリアルシステム。日大医学雑誌 64(6)337-339, 2005

9. 相馬正義:候補遺伝子アプローチ(日大方式)。血圧 12(8):839-842, 2005.

8. 相馬正義:高血圧と遺伝子異常。日大医学雑誌 63(11,12):527-528, 2004.

7. 相馬正義:糖尿病合併高血圧患者にCa拮抗薬の第1選択は適切か? Medicina 41(1):123-124, 2004.1

6. 相馬正義:糖尿病とβ遮断薬の関係は?肥満と糖尿病 3(1):144-145, 2004.1

5. 相馬正義:加齢とともにおこる骨粗鬆症―治療はここまで可能―。教育医療 29(10):2-3, 2003.10

4. 相馬正義:遺伝子と健康。教育医療 28(7):4-5, 2002.7

3. 相馬正義:どのような場合に二次性高血圧症の精査をすべきか。Medical Practice 17:783-786, 2000.5

2. Soma M, Nakayama T, Kanmatsuse K. NOS gene polymorphism and its influence on cardiovascular disease. Cur Opinion in Nephrol Hypertens 8:83-87, 1999.1

1. 相馬正義、本多正信、泉洋一、波多野道信: Hypertensinogenic steroid. 日本臨床 47:pp.2104-2108, 1989.9


 このページのトップへ戻る

著書
7. 相馬正義:新・病態生理できった内科学 4.内分泌疾患。村川裕二総監修、医学教育出版、2006.9

6. 相馬正義:研修医必携 薬物療法と禁忌。骨粗鬆症。岡田一義、福田昇、松本紘一監修、東京医学社、2005.4

5. 相馬正義:研修医必携 薬物療法と禁忌。視床下部・下垂体疾患。岡田一義、福田昇、松本紘一監修、東京医学社、2005.4

4. Nakayama T, Soma M, Kanmatsuse K. Organization of the human prostacyclin synthase gene and association analysis of a novel CA repeats in essential hypertension. Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research, Edited by Sinzinger et al. pp127-130, 1998.4

3. 相馬正義、泉洋一、上松瀬勝男:高血圧ケースセミナー。矢崎義雄監修、メディカルジャーナル社、1997.8

2. Watanabe Y, Matsuoka M. Soma M, Izumi Y, Yasugi T: Effect of docosahexaenoic acid ethylester on fatty acid composition of aorta and liver in Dahl salt sensitive or resistant rats. Advances in Polyunsaturated Fatty Acid Research, edited by T.Yasugi, H. Nakamura and M. Soma, pp185-186, Excepta Medica, Amsterdam, 1993.5

1. Matsuoka M, Watanabe Y, Soma M, Izumi Y, Yasugi T: Effects of docosahexaenoic acid on blood pressure, fatty acid composition of kidney and renal prostaglandins in Dahl salt sensitive rats. Advances in Polyunsaturated Fatty Acid Research, edited by T. Yasugi, H. Nakamura and M. Soma, pp183-184, Excepta Medica, Amsterdam, 1993.5


 このページのトップへ戻る

その他
6. 相馬正義。カロリー制限と寿命と遺伝子。東京都医師会雑誌、第60巻 第6号(19.7.15)

5. 相馬正義。日本大学医学部がめざすPBLテュートリアル。日大医学雑誌、65(1):79-80,2006

4. 相馬正義。生活習慣病の解明、DNA解析が予防と治療に寄与。日大板橋病院だより、No.21,pp11-13, 2005.7

3. 相馬正義、松本紘一、道場信孝、日野原重明。ビタミンD受容体遺伝子多型は高齢者の腰椎骨密度と相関する。財団法人ライフ・プランニングセンター研究業績年報、2004(25):58-59, 2005

2. 岡田一義、工藤たみよ、小松一俊、相馬正義、斉藤聡、松本紘一。インフルエンザ感染防止対策マニュアルの問題点。日大医学雑誌、63(1):43-45, 2004.

1. 相馬正義。学会トピックス。第25回 日本高血圧学会総会。Atherothrombosis 6(1):39, 2004


 このページのトップへ戻る